Dr. Mercola’s new book delves deep, and disses most diets 06/26/2017
Joseph Mercola, D.O., founded one of the most-visited health websites in the world.
And his enormous number of newsletter subscribers gives his views very wide reach and influence.
His latest book, “Fat for Fuel”, focuses on the ketogenic diet, and its potential for enhancing brain health, giving us more energy, and fighting cancer.
Ketogenic diets strictly limit foods high in carbohydrates — sugars and starches — and rely instead on fats to provide most daily calories.
Dr. Mercola promotes ketogenic diets because he believes they improve metabolic health, partly by protecting the tiny “energy factories” in our cells called mitochondria (my-toe-kon-dree-ah).
That’s why he calls his unique new program Mitochondrial Metabolic Therapy (MMT).
Our mitochondria are vulnerable to damage by the unstable molecules called free radicals.
And producing cellular energy from glucose — which the body makes from carbohydrates — generates many more free radicals, versus production of energy from ketones, which the body makes from dietary fats.
Accordingly, Dr. Mercola’s MMT program combines a “high-fat, low-carb, adequate-protein” diet designed to generate ketones in the body, and minimize free radicals.
His program also calls for periodic but mild fasting, and use of food-weight scales and at-home blood sugar and ketone tests.
Dr. Mercola advises adherence to the full program for people who either have or run higher risks of cancer, type 2 diabetes, dementia, obesity, and cardiovascular disease.
But he stresses that his program — which is rather rigorous if followed to the letter — can be adjusted (and relaxed) to fit your needs or goals.
What are ketogenic diets?
As we said, ketogenic diets avoid most sugars and starches, limit protein to modestly adequate amounts, and rely on fats to provide most calories.
When the body lacks enough blood sugar (glucose) for energy, it burns fats instead, and this results in a build-up of acids called ketones.
Very-low-carb diets are “ketogenic”, and force the body to rely on fat as fuel, making it much less reliant than usual on carbohydrates.
Ketogenic diets were first used to treat people with epilepsy, but gain much greater fame with the popularity of Dr. Atkins’s famed low-carb diet.
Under pressure from critics who warned (inaccurately) about the dangers of ketogenic diets, Dr. Atkins later changed his plan to rely more heavily on protein than fat.
Growing evidence shows that ketogenic diets can enhance metabolic and brain health while reducing inflammation and discouraging cancer growth — the key reasons why Dr. Mercola promotes reliance on fat for fuel.
And, as he points out in his new book, a truly ketogenic diet provides considerably less protein and more fat than the Atkins Diet or the typical Paleo-style diet.
Dr. Mercola critiques Atkins- and Paleo-style diets, saying that most Americans already pack in too much protein, and that these high-protein diets exacerbate that excess.
Let’s examine three claims that Dr. Mercola makes for his Mitochondrial Metabolic Therapy program, which rests on a ketogenic foundation.
Ketones versus cancer
The apparent ability of ketogenic diets to curb cancer growth is another proposed benefit of Dr. Mercola’s MMT program.
The idea that tumors can be curbed by starving their cancerous cells of glucose was first proposed early in the 20th century by Nobel Prize-winning biochemist Otto Warburg, M.D.
His hypothesis is backed by growing evidence that tumors struggle to thrive or even survive on a ketogenic diet, which is by definition very low in the carbs and sugars that the body converts into glucose.
This does not mean ketogenic diets can necessarily cure or even curb the growth of any given cancer.
But mainstream cancer doctors are increasingly excited about ketogenic diets as important allies (Allen BG et al. 2014; Vergati M et al. 2017; Zahra A et al. 2017).
Ketogenic diets for energy?
Dr. Mercola asserts that a ketogenic diet can make you more energetic.
That makes intuitive sense, given the energy roller-coaster induced by carb-rich diets.
Eating rapidly digested starches and sugars causes a spike in blood sugar, followed by an insulin-induced plunge that leaves you feeling fatigued.
However, the medical literature doesn’t seem to support the idea that ketogenic diets increase people’s perception of energy, or consistently enhance their athletic performance (Burke LM. 2015; Paoli A et al. 2015; Chang CK, et al. 2017).
That said, there’s some evidence that — after a period of adaptation — endurance athletes may perform better on a ketogenic diet.
And while non-obese people may respond differently, the results of some trials suggest that ketogenic diets may be unhelpful with regard to exercise and weight loss in obese people (McClernon FJ et al. 2007; Rankin JW et al. 2007; Brinkworth GD et al. 2009).
Ketogenic diets fight brain fog
Three years ago, we reported the encouraging results of a small clinical study from UCLA.
The UCLA team tested a low-carb, high-fat diet in 10 men and women who suffered from memory and/or thinking problems:
- More fat, fewer carbs.
- More vegetables, fruits, and wild fish
- No starchy carbohydrates (white flour goods; potatoes)
- More antioxidant-rich foods (berries, cocoa, coffee, tea, colorful veggies, greens)
Nine of 10 participants showed “marked” improvement, providing preliminary evidence that memory loss can be reversed through diet changes. (For more details, see Can Dementia be Defeated Naturally?.)
This result echoed positive indications seen in earlier studies, and have since been affirmed by several others.
There’s growing evidence that Alzheimer’s disease is either caused or accelerated by a decline in the brain’s ability to use glucose as fuel, which leads to the death of brain cells (Ciavardelli D et al. 2016; Ohnuma T et al. 2016; Cunnane SC et al. 2016).
So, researchers have been testing the effects of dietary ketones — or ketogenic diets — on people with dementia — with remarkably encouraging results.
It turns out that the aging brain is more than happy to burn ketones instead of glucose as fuel, which appears to help keep it functioning.
Encouraging results were obtained from several studies that tested the brain-performance effects of medium chain triglycerides or MCTs, which the body typically and readily converts into ketones.
Likewise, the primary ketones the body makes from MCTs — beta-hydroxybutyrate (β-HBA) and acetoacetate (ACAC) — have also been tested in people with mild cognitive impairment (“brain fog”) and in people at various stages of Alzheimer’s disease.
Most studies found that MCTs and ketones improved brain performance in people with mild cognitive impairment or Alzheimer’s.
However, most studies detected substantial differences between people who carry the APOE4 gene variant (a major risk factor for Alzheimer’s) and those who don’t, with the former benefiting the most.
Where can you get MCTs?
Coconut oil is the best commonly available source of MCTs — specifically, lauric, caprylic, and capric fatty acids.
The other rich source of MCTs is palm kernel oil, which is harder to find, and many if not most palm plantations employ unsustainable methods that wreak havoc on tropical forests.
Lauric acid constitutes about half the fat in coconut oil. In contrast to caprylic and capric acid, lauric acid produces fewer ketones and it’s metabolized in the liver.
That’s why many advocates — such as Dave Asprey of Bulletproof Coffee fame — recommend “MCT oils” formulated to contain primarily caprylic and capric acid.
However, a recent study showed that coconut oil produced more ketones than either caprylic or capric acid alone, which makes sense, given the very large amount of lauric acid in coconut oil (Cunnane SC et al. 2016).
MCTs are saturated fats, the category commonly — albeit controversially — blamed for raising cardiovascular risks.
But the results of a recent study found that consuming 30 grams (about one ounce) of MCTs for 30 days did not adversely affect blood sugar, insulin, triglyceride, or cholesterol levels (Courchesne-Loyer et al. 2013).
Beyond MCTs: Caffeine and omega-3s also yield ketones
MCTs are not the only way in which diet can produce more ketones.
It turns out that caffeine and the plant source omega-3 called ALA both generate ketones.
This may be a partial explanation for the demonstrated ability of coffee, tea, and omega-3s to enhance brain performance.
A final note on “Fat for Fuel”
We recommend Dr. Mercola's new book, with one caveat.
As he says in the book's introduction, research is constantly advancing, and could make some of his points obsolete.
But we think it’s better to act on what's known now, rather than wait for health authorities to issue firm opinions.
Official guidance is equally vulnerable to obsolescence, and it's much harder for high-profile agencies to admit error.
We should note that Dr. Mercola’s website presents controversial positions on topics like vaccines and fluoridation of water.
Unsurprisingly, his more controversial views are disputed vigorously by scientists active in those fields.
That said, he beneficially focuses people's attention on diet and lifestyle as first-line strategies for preventing and treating our most common health conditions.
And we admire his willingness to explore the frontiers of science to help people achieve optimal health.
- Allen BG et al. Ketogenic diets as an adjuvant cancer therapy: History and potential mechanism. Redox Biol. 2014; 2: 963–970. Published online 2014 Aug 7. doi: 10.1016/j.redox.2014.08.002
- Branco AF, Ferreira A, Simões RF, Magalhães-Novais S, Zehowski C, Cope E, Silva AM, Pereira D, Sardão VA, Cunha-Oliveira T. Ketogenic diets: from cancer to mitochondrial diseases and beyond. Eur J Clin Invest. 2016 Mar;46(3):285-98. doi: 10.1111/eci.12591. Review.
- Bredesen DE, John V. Next generation therapeutics for Alzheimer's disease. EMBO Mol Med. 2013 Jun;5(6):795-8. doi: 10.1002/emmm.201202307. Epub 2013 May 23.
- Bredesen DE. Reversal of cognitive decline: A novel therapeutic program. Aging. September 27, 2014. Accessed at http://www.impactaging.com/papers/v6/n9/abs/100690a.html
- Brinkworth GD, Noakes M, Clifton PM, Buckley JD. Effects of a low carbohydrate weight loss diet on exercise capacity and tolerance in obese subjects. Obesity (Silver Spring). 2009 Oct;17(10):1916-23. doi: 10.1038/oby.2009.134. Epub 2009 Apr 16.
- Burke LM. Re-Examining High-Fat Diets for Sports Performance: Did We Call the 'Nail in the Coffin' Too Soon? Sports Med. 2015 Nov;45 Suppl 1:S33-49. doi: 10.1007/s40279-015-0393-9. Review.
- Chang CK, Borer K, Lin PJ. Low-Carbohydrate-High-Fat Diet: Can it Help Exercise Performance? J Hum Kinet. 2017 Mar 12;56:81-92. doi: 10.1515/hukin-2017-0025. eCollection 2017 Feb.
- Cheng B, Yang X, An L, Gao B, Liu X, Liu S. Ketogenic diet protects dopaminergic neurons against 6-OHDA neurotoxicity via up-regulating glutathione in a rat model of Parkinson's disease. Brain Res. 2009 Aug 25;1286:25-31. doi: 10.1016/j.brainres.2009.06.060. Epub 2009 Jun 25.
- Ciara H. O’Flanagan, Laura A. Smith, Shannon B. McDonell, Stephen D. Hursting When less may be more: calorie restriction and response to cancer therapy. BMC Med. 2017; 15: 106. Published online 2017 May 24. doi: 10.1186/s12916-017-0873-x
- Ciavardelli D, Piras F, Consalvo A, Rossi C, Zucchelli M, Di Ilio C, Frazzini V, Caltagirone C, Spalletta G, Sensi SL. Medium-chain plasma acylcarnitines, ketone levels, cognition, and gray matter volumes in healthy elderly, mildly cognitively impaired, or Alzheimer's disease subjects. Neurobiol Aging. 2016 Jul;43:1-12. doi: 10.1016/j.neurobiolaging.2016.03.005. Epub 2016 Mar 15.
- Courchesne-Loyer A, Fortier M, Tremblay-Mercier J, Chouinard-Watkins R, Roy M, Nugent S, Castellano CA, Cunnane SC. Stimulation of mild, sustained ketonemia by medium-chain triacylglycerols in healthy humans: estimated potential contribution to brain energy metabolism. Nutrition. 2013 Apr;29(4):635-40. doi: 10.1016/j.nut.2012.09.009. Epub 2012 Dec 28.
- Cunnane SC, Courchesne-Loyer A, St-Pierre V, Vandenberghe C, Pierotti T, Fortier M, Croteau E, Castellano CA. Can ketones compensate for deteriorating brain glucose uptake during aging? Implications for the risk and treatment of Alzheimer's disease. Ann N Y Acad Sci. 2016 Mar;1367(1):12-20. doi: 10.1111/nyas.12999. Epub 2016 Jan 14.
- Cunnane SC, Courchesne-Loyer A, Vandenberghe C, St-Pierre V, Fortier M, Hennebelle M, Croteau E, Bocti C, Fulop T, Castellano CA. Can Ketones Help Rescue Brain Fuel Supply in Later Life? Implications for Cognitive Health during Aging and the Treatment of Alzheimer's Disease. Front Mol Neurosci. 2016 Jul 8;9:53. doi: 10.3389/fnmol.2016.00053. eCollection 2016.
- El-Mallakh RS, Paskitti ME. The ketogenic diet may have mood-stabilizing properties. Med Hypotheses. 2001 Dec;57(6):724-6.
- Eric C. Woolf, Nelofer Syed, Adrienne C. Scheck. Tumor Metabolism, the Ketogenic Diet and β-Hydroxybutyrate: Novel Approaches to Adjuvant Brain Tumor Therapy. Front Mol Neurosci. 2016; 9: 122. Published online 2016 Nov 16. doi: 10.3389/fnmol.2016.00122
- Farah BA. Effects of caprylic triglyceride on cognitive performance and cerebral glucose metabolism in mild Alzheimer's disease: a single-case observation. Front Aging Neurosci. 2014 Jul 16;6:133. doi: 10.3389/fnagi.2014.00133. eCollection 2014.
- Gasior M, Rogawski MA, Hartman AL. Neuroprotective and disease-modifying effects of the ketogenic diet. Behav Pharmacol. 2006 Sep;17(5-6):431-9. Review.
- Han JR, Deng B, Sun J, Chen CG, Corkey BE, Kirkland JL, Ma J, Guo W. Effects of dietary medium-chain triglyceride on weight loss and insulin sensitivity in a group of moderately overweight free-living type 2 diabetic Chinese subjects. Metabolism. 2007 Jul;56(7):985-91.
- Hashim SA, VanItallie TB. Ketone body therapy: from the ketogenic diet to the oral administration of ketone ester. J Lipid Res. 2014 Sep;55(9):1818-26. doi: 10.1194/jlr.R046599. Epub 2014 Mar 5. Review.
- Henderson ST et al. (2009). Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer’s disease: a randomized, double-blind, placebo-controlled, multicenter trial. Nutr. Metab. (Lond.) 6:31 10.1186/1743-7075-6-31
- Henderson ST, Poirier J. Pharmacogenetic analysis of the effects of polymorphisms in APOE, IDE and IL1B on a ketone body based therapeutic on cognition in mild to moderate Alzheimer's disease; a randomized, double-blind, placebo-controlled study. BMC Med Genet. 2011 Oct 12;12:137. doi: 10.1186/1471-2350-12-137.
- Henderson ST, Vogel JL, Barr LJ, Garvin F, Jones JJ, Costantini LC. Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial. Nutr Metab (Lond). 2009 Aug 10;6:31. doi: 10.1186/1743-7075-6-31.
- Henderson ST. Ketone bodies as a therapeutic for Alzheimer's disease. Neurotherapeutics. 2008 Jul;5(3):470-80. doi: 10.1016/j.nurt.2008.05.004. Review.
- Hertz L, Chen Y, Waagepetersen HS. Effects of ketone bodies in Alzheimer's disease in relation to neural hypometabolism, β-amyloid toxicity, and astrocyte function. J Neurochem. 2015 Jul;134(1):7-20. doi: 10.1111/jnc.13107. Epub 2015 Apr 23. Review.
- Krikorian R, Shidler MD, Dangelo K, Couch SC, Benoit SC, Clegg DJ. Dietary ketosis enhances memory in mild cognitive impairment. Neurobiol Aging. 2012 Feb; 33(2):425.e19-27.
- Liśkiewicz AD et al. Long-term High Fat Ketogenic Diet Promotes Renal Tumor Growth in a Rat Model of Tuberous Sclerosis. Sci Rep. 2016; 6: 21807. Published online 2016 Feb 19. doi: 10.1038/srep21807
- McClernon FJ, Yancy WS Jr, Eberstein JA, Atkins RC, Westman EC. The effects of a low-carbohydrate ketogenic diet and a low-fat diet on mood, hunger, and other self-reported symptoms. Obesity (Silver Spring). 2007 Jan;15(1):182-7.
- Morscher RJ, Aminzadeh-Gohari S, Feichtinger RG, Mayr JA, Lang R, Neureiter D, Sperl W, Kofler B. Inhibition of Neuroblastoma Tumor Growth by Ketogenic Diet and/or Calorie Restriction in a CD1-Nu Mouse Model. PLoS One. 2015 Jun 8;10(6):e0129802. doi: 10.1371/journal.pone.0129802. eCollection 2015.
- Murphy P, Likhodii S, Nylen K, Burnham WM. The antidepressant properties of the ketogenic diet. Biol Psychiatry. 2004 Dec 15;56(12):981-3.
- Newport MT, VanItallie TB, Kashiwaya Y, King MT, Veech RL. A new way to produce hyperketonemia: use of ketone ester in a case of Alzheimer's disease. Alzheimers Dement. 2015 Jan;11(1):99-103. doi: 10.1016/j.jalz.2014.01.006. Epub 2014 Oct 7.
- Ohnuma T, Toda A, Kimoto A, Takebayashi Y, Higashiyama R, Tagata Y, Ito M, Ota T, Shibata N, Arai H. Benefits of use, and tolerance of, medium-chain triglyceride medical food in the management of Japanese patients with Alzheimer's disease: a prospective, open-label pilot study. Clin Interv Aging. 2016 Jan 8;11:29-36. doi: 10.2147/CIA.S95362. eCollection 2016.
- Ota M, Matsuo J, Ishida I, Hattori K, Teraishi T, Tonouchi H, Ashida K, Takahashi T, Kunugi H. Effect of a ketogenic meal on cognitive function in elderly adults: potential for cognitive enhancement. Psychopharmacology (Berl). 2016 Oct;233(21-22):3797-3802. Epub 2016 Aug 27.
- Page KA, Williamson A, Yu N, McNay EC, Dzuira J, McCrimmon RJ, Sherwin RS Medium-chain fatty acids improve cognitive function in intensively treated type 1 diabetic patients and support in vitro synaptic transmission during acute hypoglycemia. Diabetes. 2009 May; 58(5):1237-44
- Pan Y, Larson B, Araujo JA, Lau W, de Rivera C, Santana R, Gore A, Milgram NW. Dietary supplementation with medium-chain TAG has long-lasting cognition-enhancing effects in aged dogs. Br J Nutr. 2010 Jun;103(12):1746-54. doi: 10.1017/S0007114510000097. Epub 2010 Feb 9.
- Paoli A, Bianco A, Grimaldi KA. The Ketogenic Diet and Sport: A Possible Marriage? Exerc Sport Sci Rev. 2015 Jul;43(3):153-62. doi: 10.1249/JES.0000000000000050. Review.
- Rainer J. Klement, Reinhart A. Sweeney. Impact of a ketogenic diet intervention during radiotherapy on body composition: I. Initial clinical experience with six prospectively studied patients. BMC Res Notes. 2016; 9: 143. Published online 2016 Mar 5. doi: 10.1186/s13104-016-1959-9
- Rankin JW, Turpyn AD. Low carbohydrate, high fat diet increases C-reactive protein during weight loss. J Am Coll Nutr. 2007 Apr;26(2):163-9.
- Rebello CJ, Keller JN, Liu AG, Johnson WD, Greenway FL. Pilot feasibility and safety study examining the effect of medium chain triglyceride supplementation in subjects with mild cognitive impairment: A randomized controlled trial. BBA Clin. 2015 Jan 16;3:123-5. doi: 10.1016/j.bbacli.2015.01.001. eCollection 2015 Jun.
- Reger MA, Henderson ST, Hale C, Cholerton B, Baker LD, Watson GS, Hyde K, Chapman D, Craft S Effects of beta-hydroxybutyrate on cognition in memory-impaired adults. Neurobiol Aging. 2004 Mar; 25(3):311-4.
- Selfridge JE, Wilkins HM, E L, Carl SM, Koppel S, Funk E, Fields T, Lu J, Tang EP, Slawson C, Wang W, Zhu H, Swerdlow RH. Effect of one month duration ketogenic and non-ketogenic high fat diets on mouse brain bioenergetic infrastructure. J Bioenerg Biomembr. 2015 Apr;47(1-2):1-11. doi: 10.1007/s10863-014-9570-z. Epub 2014 Aug 8.
- Sharma A, Bemis M, Desilets AR. Role of Medium Chain Triglycerides (Axona®) in the Treatment of Mild to Moderate Alzheimer's Disease. Am J Alzheimers Dis Other Demen. 2014 Aug;29(5):409-14. doi: 10.1177/1533317513518650. Epub 2014 Jan 9. Review.
- Simons AL, Mattson DM, Dornfeld K, Spitz DR. Glucose deprivation-induced metabolic oxidative stress and cancer therapy. J Cancer Res Ther. 2009 Sep;5 Suppl 1:S2-6. doi: 10.4103/0973-1482.55133. Review.
- Soheila Khodadadi, Nafiseh Sobhani, Somaye Mirshekar, Reza Ghiasvand, Makan Pourmasoumi, Maryam Miraghajani, Somayeh Shahraki Dehsoukhteh. Tumor Cells Growth and Survival Time with the Ketogenic Diet in Animal Models: A Systematic Review. Int J Prev Med. 2017; 8: 35. Published online 2017 May 25. doi: 10.4103/2008-7802.207035
- Tremblay AJ, Lamarche B, Labonté MÈ, Lépine MC, Lemelin V, Couture P. Dietary medium-chain triglyceride supplementation has no effect on apolipoprotein B-48 and apolipoprotein B-100 kinetics in insulin-resistant men. Am J Clin Nutr. 2014 Jan;99(1):54-61. doi: 10.3945/ajcn.113.068767. Epub 2013 Oct 30.
- Vergati M, Krasniqi E, Del Monte G, Riondino S, Vallone D, Guadagni F, Ferroni P, Roselli M. Ketogenic diet and other dietary intervention strategies in the treatment of cancer. Curr Med Chem. 2017 Jan 16. [Epub ahead of print]
- Vidali S, Aminzadeh S, Lambert B, Rutherford T, Sperl W, Kofler B, Feichtinger RG. Mitochondria: The ketogenic diet--A metabolism-based therapy. Int J Biochem Cell Biol. 2015 Jun;63:55-9. doi: 10.1016/j.biocel.2015.01.022. Epub 2015 Feb 7. Review.
- Wartchow KM, Tramontina AC, de Souza DF, Biasibetti R, Bobermin LD, Gonçalves CA. Insulin Stimulates S100B Secretion and These Proteins Antagonistically Modulate Brain Glucose Metabolism. Neurochem Res. 2016 Jun;41(6):1420-9. doi: 10.1007/s11064-016-1851-y. Epub 2016 Feb 15.
- White AM, Johnston CS, Swan PD, Tjonn SL, Sears B. Blood ketones are directly related to fatigue and perceived effort during exercise in overweight adults adhering to low-carbohydrate diets for weight loss: a pilot study. J Am Diet Assoc. 2007 Oct;107(10):1792-6.
- Zahra A et al. Consuming a Ketogenic Diet while Receiving Radiation and Chemotherapy for Locally Advanced Lung Cancer and Pancreatic Cancer: The University of Iowa Experience of Two Phase 1 Clinical Trials. Radiat Res. 2017 Jun;187(6):743-754. doi: 10.1667/RR14668.1. Epub 2017 Apr 24.